We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Modifier Gene Active in Neurologic Disease Model

By Biotechdaily staff writers
Posted on 02 Sep 2003
Researchers have found that the severity of certain types of inherited neurologic disorders is influenced by a specific modifier gene that interacts with other genes to modulate the physical effects of the disease.

Investigators at the University of Michigan (Ann Arbor, USA) used C57BL/6J mice to study the sodium channel genes whose products control the flow of electrical signals between nerve and muscle cells. Mutations in sodium channel genes produce a variety of neurologic disorders including several types of epilepsy, ataxia, poor muscle coordination, paralysis, and cardiac arrhythmias. C57BL/6J mice possess a mutation in the Scn8a sodium channel gene.

"In our study with mice, we found that the severity of neurological defects caused by mutations in a gene called Scn8a are determined by another gene, Scnm1, which is located on a different chromosome,” explained senior author Dr. Miriam Meisler, professor of human genetics in the University of Michigan Medical School. "Scnm1 is expressed in many human cells, which suggests that it could modify the severity of a wide range of inherited disorders in humans, including other neurological diseases.”

The authors reported in a paper published in the August 15, 2003, issue of Science that the presence of the mutation caused the mice to produce an inadequate amount of critical sodium channel proteins. Mice with two copies of the mutated modifier gene had only 5% of the normal amount of functional Scn8a protein and died soon after birth.

"Now that we have identified the gene and the mechanism by which it works, as well as the precise chromosome location of the human gene, we can begin looking for interactions with other mutations associated with human neurological disorders like epilepsy,” said Dr. Meisler. "This modifier is likely to interact with other types of genes, in addition to human sodium channels. If we can find a way to change the secondary effects of modifier genes, we may be able to minimize the impact of the original genetic defect.”

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
HPV Molecular Test
BD Onclarity HPV Assay

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
02 Sep 2003  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
02 Sep 2003  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
02 Sep 2003  |   BioResearch